|
|
Post by celo on Mar 3, 2021 11:28:34 GMT -5
The volume causing the steep decline looks to have dried up. That may have happened because we are at such a low price point the sellers are waiting for a better price or they ran out of shares. Still hasn't pushed out of the downward trend.
|
|
|
|
Post by longliner on Mar 3, 2021 11:32:30 GMT -5
The volume causing the steep decline looks to have dried up. That may have happened because we are at such a low price point the sellers are waiting for a better price or they ran out of shares. Still hasn't pushed out of the downward trend. I'm waiting to be sure they have thoroughly ripped our guts out before capping off my ungodly buying spree.  |
|
|
|
Post by celo on Mar 3, 2021 12:05:08 GMT -5
The volume causing the steep decline looks to have dried up. That may have happened because we are at such a low price point the sellers are waiting for a better price or they ran out of shares. Still hasn't pushed out of the downward trend. I'm waiting to be sure they have thoroughly ripped our guts out before capping off my ungodly buying spree. I think you are not alone. I think a lot of buyers are waiting on the sidelines to make sure the selling has stopped. Could be tomorrow...could be whenever... |
|
|
|
Post by longliner on Mar 3, 2021 12:08:35 GMT -5
I'm waiting to be sure they have thoroughly ripped our guts out before capping off my ungodly buying spree. I think you are not alone. I think a lot of buyers are waiting on the sidelines to make sure the selling has stopped. Could be tomorrow...could be whenever... I'm going with the thesis that we get some clarity on the capital raise tomorrow, that should create positive tailwinds and am investing as such. I've never been wrong before about Mannkind.....   |
|
|
|
Post by peppy on Mar 3, 2021 12:46:54 GMT -5
The volume causing the steep decline looks to have dried up. That may have happened because we are at such a low price point the sellers are waiting for a better price or they ran out of shares. Still hasn't pushed out of the downward trend. I'm waiting to be sure they have thoroughly ripped our guts out before capping off my ungodly buying spree. Yes, volume has dried up. Volume at the half day of trade, real time, 2,325,898 summary, 4,548,516 Avg. Volume 6,008,786 3.705. -0.075 (-1.9841%) As of 12:46PM EST. Market open. |
|
|
|
Post by longliner on Mar 3, 2021 14:54:09 GMT -5
A big buy just hit. 300 thousand shares. A second 300,000 buy just hit....
|
|
|
|
Post by veritasfiliatemporis on Mar 3, 2021 15:07:59 GMT -5
Bought 4000 at 3.66 🤔
|
|
|
|
Post by longliner on Mar 3, 2021 15:25:07 GMT -5
I haven't bought a thing yet today....I just know the second I do they'll knock the heck out of the bottom. Toads I grabbed 1000 at 3.64, the price went straight to 3.61 within seconds!  |
|
|
|
Post by lazyb767 on Mar 3, 2021 16:00:18 GMT -5
4500 @ 3.64
|
|
|
|
Post by sportsrancho on Mar 3, 2021 16:03:27 GMT -5
|
|
|
|
Post by Chris-C on Mar 3, 2021 16:06:22 GMT -5
So, you say the share price is back to where it was a month ago, and the company is now saddled with hundreds of millions of dollars of new debt? When you put it like that, I'm even more thankful that the SP has not fallen further. The reason a company is a “pubic” company is because of the need or desire to capitalize their operations. In return for money, they agree to sell equity; a right of ownership in a portion of their company. But there is more obligation than just selling ownership. They’re also agreeing to voting rights (usually), and in some cases a preferred portion to proceeds of liquidation if the company should go bankrupt. But there is still more obligation. At some point of corporate maturity, the shareholders want dividends; a cash distribution of some portion of profit. Corporate finance using other people’s money comes down to two main options; equity or debt. If you study the cost of those two methods of capitalization, the more expensive option is equity because of dividends. In the long run, it is always(?) cheaper to capitalize with debt than it is with equity, because a debt can be paid with no further obligation. You may remember that I’ve been enthusiastic about Mannkind’s improving prospects and that one of the main points of my enthusiasm was that at some point Mannkind would be able to be capitalized on much better, non-toxic, terms than they have for most of the last 7 years. Guess what? We reached that point sooner than I expected, I think. Almost everybody is amazed by the grossly favorable terms of the capitalization. But, are they really grossly favorable? We’ll know more soon. For now, on the face of it, and I think the buoyancy in the stock price underscores this, we should be very happy with this news. The bigger issue now becomes how will Mannkind use this money? I’ve been convinced for a year or so (thanks to Matt, Aged, and a PCP), that for Mannkind to flourish with Afrezza specifically, Mannkind had to address insurance coverage, and prescriber reluctance based on the paucity of convincing safety and efficacy data from clinical trials, and that meant raising a lot of money and therefore on reasonable financial terms because a lot of money on toxic terms is really only a tourniquet designed to stop the bleeding but you may lose a limb or your life. This isn’t a tourniquet. It’s an investment shot in the arm. Good post and I mostly agree with everything you wrote. But, I’m not convinced that safety concerns are a big factor in holding back potential Afrezza prescribers. The product has been dosed for years with thousands of PWD’s, and there is no indication that it significantly harms pulmonary function. As you know, the spirometry requirement was added by FDA on the advice of the advisory committee (as I recall), to exercise an abundance of caution. But, If inhaling technosphere molecules is harmful, then potentially the entire future of the company is in jeopardy, and FDA monitoring for adverse events with Afrezza would have already sounded an alert by now, one would conjecture. It seems that what we need are providers who have the time and motivation to try something that results in better management of diabetes without a steep learning curve, does not involve risk or completion of prior authorization requests for insurance companies, and does not greatly increase insulin costs for their patients. We also need patients who are motivated to manage their own disease more effectively and change their own established regimens. Tall orders, those. Script numbers show that over time, Afrezza will slowly gain traction. I’m sure that MC and his execs have a good reason for moving ahead with peds and I suspect it has to do with a target population of patients and providers who are less entrenched in the status quo. If the added revenue from peds approval can make Afrezza a break even product, resources can then be directed toward more lucrative pipeline candidates. The big thing about Tyvaso DPI is the message it sends to the market that MNKD is not defined by Afrezza. The next partnership or pipeline drug beyond Tyvaso will be the “hat trick” that really underscores the vast potential that the technology has for many potential indications. That will be when the rocket really takes off, IMO. So there is a lot riding on the company’s choice of the next pipeline candidate beyond Tyvaso DPI. |
|
|
|
Post by buyitonsale on Mar 3, 2021 16:10:37 GMT -5
Buy order for 3.57 set for tomorrow. Based on a 3 month chart hopefully 3.52 area should be support.
|
|
|
|
Post by longliner on Mar 3, 2021 16:14:58 GMT -5
Buy order for 3.57 set for tomorrow. Based on a 3 month chart hopefully 3.52 area should be support. That's exactly where my order (3.57) sat until just before close. Hoping for an update in the AM. If not, nice call on your part. |
|
|
|
Post by Chris-C on Mar 3, 2021 16:36:07 GMT -5
Buy order for 3.57 set for tomorrow. Based on a 3 month chart hopefully 3.52 area should be support. That's exactly where my order (3.57) sat until just before close. Hoping for an update in the AM. If not, nice call on your part. Don’t count on it. I had an order in for 3.62 all day and decided to increase it-thinking an announcement might come in the morning to reverse the trend. Instead, my trade at 3.65 was the signal to send it lower, apparently. You’re welcome. |
|
|
|
Post by BD on Mar 3, 2021 17:09:53 GMT -5
Superstitious, anyone? LOL
(this is about the thread being moved back here from the TA forum)
|
|
